Arrowhead Pharmaceuticals Inc. (ARWR)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Waddill Director	$68.53	500	$34,265.00	56,563	2025-12-19	Filing
Waddill Director	$68.01	5,451	$370,722.51	57,063	2025-12-19	Filing
Waddill Director	$66.66	2,416	$161,050.56	62,514	2025-12-19	Filing
Vakiener Director	$68.39	1,960	$134,044.40	35,723	2025-12-19	Filing
Vakiener Director	$67.97	5,281	$358,949.57	37,683	2025-12-19	Filing
Vakiener Director	$66.63	2,799	$186,497.37	42,964	2025-12-19	Filing
Anzalone Officer, Director	$68.85	2,574	$177,219.90	3,805,926	2025-12-22	Filing
Anzalone Officer, Director	$68.33	10,012	$684,119.96	3,808,500	2025-12-22	Filing
Anzalone Officer, Director	$68.48	1,319	$90,325.12	3,818,512	2025-12-19	Filing
Anzalone Officer, Director	$68.01	8,147	$554,077.47	3,819,831	2025-12-19	Filing
Anzalone Officer, Director	$66.67	3,979	$265,279.93	3,827,978	2025-12-19	Filing
Olukotun Director	$68.48	827	$56,632.96	33,600	2025-12-19	Filing
Olukotun Director	$68.04	6,083	$413,887.32	34,427	2025-12-19	Filing
Olukotun Director	$66.70	3,090	$206,103.00	40,510	2025-12-19	Filing
Anzalone Officer, Director	$66.30	1,981	$131,340.30	3,831,957	2025-12-17	Filing
Anzalone Officer, Director	$65.53	982	$64,350.46	3,833,938	2025-12-17	Filing
Anzalone Officer, Director	$64.51	35,750	$2,306,232.50	3,834,920	2025-12-17	Filing
Anzalone Officer, Director	$63.55	46,287	$2,941,538.85	3,870,670	2025-12-17	Filing
Anzalone Officer, Director	$67.87	3,221	$218,609.27	3,916,957	2025-12-16	Filing
Anzalone Officer, Director	$66.77	166	$11,083.82	3,920,178	2025-12-16	Filing